BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
Number Cited Articles
1
Zhao-Xia Wang, Dong Xue, Zhi-Li Liu, Bin-Bin Lu, Hai-Bo Bian, Xuan Pan, Yong-Mei Yin. Overexpression of polo-like kinase 1 and its clinical significance in human non-small cell lung cancerThe International Journal of Biochemistry & Cell Biology 2012; 44(1): 200 doi: 10.1016/j.biocel.2011.10.017
2
Mao-Wei Cheng, Bing-Chan Wang, Zhi-Qiang Weng, Xiao-Wei Zhu. Clinicopathological significance of Polo-like kinase 1 (PLK1) expression in human malignant gliomaActa Histochemica 2012; 114(5): 503 doi: 10.1016/j.acthis.2011.09.004
3
Ion Cristóbal, Federico Rojo, Juan Madoz-Gúrpide, Jesús García-Foncillas. Cross Talk between Wnt/β-Catenin and CIP2A/Plk1 Signaling in Prostate Cancer: Promising Therapeutic ImplicationsMolecular and Cellular Biology 2016; 36(12): 1734 doi: 10.1128/MCB.00130-16
4
Zhixian Liu, Qingrong Sun, Xiaosheng Wang. PLK1, A Potential Target for Cancer TherapyTranslational Oncology 2017; 10(1): 22 doi: 10.1016/j.tranon.2016.10.003
5
Ourania M. Andrisani, Leo Studach, Philippe Merle. Gene signatures in hepatocellular carcinoma (HCC)Seminars in Cancer Biology 2011; 21(1): 4 doi: 10.1016/j.semcancer.2010.09.002
6
Yuehong Wang, Linying Wu, Yinan Yao, Guohua Lu, Liming Xu, Jianying Zhou. Polo-like kinase 1 inhibitor BI 6727 induces DNA damage and exerts strong antitumor activity in small cell lung cancerCancer Letters 2018; 436: 1 doi: 10.1016/j.canlet.2018.08.007
7
Zili He, Wen Deng, Bo Jiang, Sulai Liu, Mingchun Tang, Yi Liu, Jian Zhang. Hsa-let-7b inhibits cell proliferation by targeting PLK1 in HCCGene 2018; 673: 46 doi: 10.1016/j.gene.2018.06.047
8
Ping Zhan, Guang-min Xi, Bin Zhang, Ying Wu, Hong-bing Liu, Ya-fang Liu, Wu-jian Xu, Qingqing Zhu, Feng Cai, Ze-jun Zhou, Ying-ying Miu, Xiao-xia Wang, Jia-jia Jin, Qian Li, Tang-feng Lv, Yong Song. NCAPG2 promotes tumour proliferation by regulating G2/M phase and associates with poor prognosis in lung adenocarcinomaJournal of Cellular and Molecular Medicine 2017; 21(4): 665 doi: 10.1111/jcmm.13010
9
Li Xu, Yuanrun Zhu, Jinjin Shao, Min Chen, Hao Yan, Guanqun Li, Yi Zhu, Zhifei Xu, Bo Yang, Peihua Luo, Qiaojun He. Dasatinib synergises with irinotecan to suppress hepatocellular carcinoma via inhibiting the protein synthesis of PLK1British Journal of Cancer 2017; 116(8): 1027 doi: 10.1038/bjc.2017.55
10
Wei Sun, Qi Su, Xiankui Cao, Bin Shang, Aishan Chen, Hongzhuan Yin, Baolin Liu. High Expression of Polo-Like Kinase 1 Is Associated with Early Development of Hepatocellular CarcinomaInternational Journal of Genomics 2014; 2014: 1 doi: 10.1155/2014/312130
11
Qiying Yi, Yang Liu, Min Cao, Jianing Liu, Qin Xiang, Guo Tan, Huatang Zhang, Guoqi Lai, Yajun Xie. Transcriptional analysis and differentially expressed gene screening of spontaneous liver tumors in CBA/CaJ miceGene 2020; 725: 144159 doi: 10.1016/j.gene.2019.144159
12
Lily Weiß, Thomas Efferth. Polo-like kinase 1 as target for cancer therapyExperimental Hematology & Oncology 2012; 1(1) doi: 10.1186/2162-3619-1-38
13
Ping Chen, Xia Zhao, Liang Ma. Downregulation of microRNA-100 correlates with tumor progression and poor prognosis in hepatocellular carcinomaMolecular and Cellular Biochemistry 2013; 383(1-2): 49 doi: 10.1007/s11010-013-1753-0
14
Ahmad Jalili, Anna Moser, Mikhail Pashenkov, Christine Wagner, Gaurav Pathria, Viola Borgdorff, Melanie Gschaider, Georg Stingl, Sridhar Ramaswamy, Stephan N. Wagner. Polo-Like Kinase 1 Is a Potential Therapeutic Target in Human MelanomaJournal of Investigative Dermatology 2011; 131(9): 1886 doi: 10.1038/jid.2011.136
15
Yuchong Peng, Youhong Liu, Yingxue Gao, Bowen Yuan, Xuli Qi, Yuxin Fu, Qianling Zhu, Tuoyu Cao, Songwei Zhang, Linglong Yin, Xiong Li. USP7 is a novel Deubiquitinase sustaining PLK1 protein stability and regulating chromosome alignment in mitosisJournal of Experimental & Clinical Cancer Research 2019; 38(1) doi: 10.1186/s13046-019-1457-8
16
Ding-pei Han, Qian-lin Zhu, Jiang-tao Cui, Pu-xiongzhi Wang, Shun Qu, Qi-feng Cao, Ya-ping Zong, Bo Feng, Min-hua Zheng, Ai-guo Lu. Polo-like kinase 1 is overexpressed in colorectal cancer and participates in the migration and invasion of colorectal cancer cellsMedical Science Monitor 2012; 18(6): BR237 doi: 10.12659/MSM.882900
17
Hicham Bouhlal, Hakim Ouled-Haddou, Véronique Debuysscher, Amrathlal Rabbind Singh, Christèle Ossart, Aline Reignier, Hakim Hocini, Gregory Fouquet, Mohammed Al Baghami, Mélanie Simoes Eugenio, Eric Nguyen-Khac, Jean-Marc Regimbeau, Ingrid Marcq. RB/PLK1-dependent induced pathway by SLAMF3 expression inhibits mitosis and control hepatocarcinoma cell proliferationOncotarget 2016; 7(9): 9832 doi: 10.18632/oncotarget.6954
18
J.C. Oliveira, J.A. Pezuk, M.S. Brassesco, A.G. Morales, R.G.P. Queiroz, C.A. Scrideli, L.G. Tone. PLK1expression and BI 2536 effects in childhood acute lymphoblastic leukemiaPediatric Blood & Cancer 2014; 61(7): 1227 doi: 10.1002/pbc.24978
19
Jörg Haupenthal, Verena Bihrer, Huedayi Korkusuz, Otto Kollmar, Christian Schmithals, Susanne Kriener, Knut Engels, Thomas Pleli, Alexander Benz, Marta Canamero, Thomas Longerich, Bernd Kronenberger, Swantje Richter, Oliver Waidmann, Thomas J. Vogl, Stefan Zeuzem, Albrecht Piiper. Reduced Efficacy of the Plk1 Inhibitor BI 2536 on the Progression of Hepatocellular Carcinoma due to Low Intratumoral Drug LevelsNeoplasia 2012; 14(5): 410 doi: 10.1596/neo.111366
20
XING-GUANG ZHANG, XIAO-FENG LU, XIU-MING JIAO, BIN CHEN, JIN-XIAO WU. PLK1 gene suppresses cell invasion of undifferentiated thyroid carcinoma through the inhibition of CD44v6, MMP-2 and MMP-9Experimental and Therapeutic Medicine 2012; 4(6): 1005 doi: 10.3892/etm.2012.729
21
Claudia Münch, Diana Dragoi, Anna-Verena Frey, Katja Thurig, Michael Lübbert, Ralph Wäsch, Lioudmila Bogatyreva, Dieter Hauschke, Silke Lassmann, Martin Werner, Annette M. May. Therapeutic polo-like kinase 1 inhibition results in mitotic arrest and subsequent cell death of blasts in the bone marrow of AML patients and has similar effects in non-neoplastic cell linesLeukemia Research 2015; 39(4): 462 doi: 10.1016/j.leukres.2015.01.007
22
Peter Dietrich, Kim Freese, Abdo Mahli, Wolfgang Erwin Thasler, Claus Hellerbrand, Anja Katrin Bosserhoff. Combined effects of PLK1 and RAS in hepatocellular carcinoma reveal rigosertib as promising novel therapeutic “dual-hit” optionOncotarget 2018; 9(3): 3605 doi: 10.18632/oncotarget.23188
23
Joshua A. McCarroll, Tanya Dwarte, Huricha Baigude, Jason Dang, Lu Yang, Rafael B. Erlich, Kathleen Kimpton, Joann Teo, Sharon M. Sagnella, Mia C. Akerfeldt, Jie Liu, Phoebe A. Phillips, Tariq M. Rana, Maria Kavallaris. Therapeutic targeting of polo-like kinase 1 using RNA-interfering nanoparticles (iNOPs) for the treatment of non-small cell lung cancerOncotarget 2015; 6(14): 12020 doi: 10.18632/oncotarget.2664
24
Nitin Sharma, Rajni Vaid, Kamal Dev, Anuradha Sourirajan. Encyclopedia of Signaling Molecules2017; : 1 doi: 10.1007/978-1-4614-6438-9_101760-1
25
A. R. Conery, E. Harlow. High-throughput screens in diploid cells identify factors that contribute to the acquisition of chromosomal instabilityProceedings of the National Academy of Sciences 2010; 107(35): 15455 doi: 10.1073/pnas.1010627107
26
Hefei Li, Haibo Wang, Zhenqing Sun, Qiang Guo, Hongyun Shi, Youchao Jia. The clinical and prognostic value of polo-like kinase 1 in lung squamous cell carcinoma patients: immunohistochemical analysisBioscience Reports 2017; 37(4) doi: 10.1042/BSR20170852
27
N. Stutz, M. Nihal, G.S. Wood. Polo-like kinase 1 (Plk1) in cutaneous T-cell lymphomaBritish Journal of Dermatology 2011; 164(4): 814 doi: 10.1111/j.1365-2133.2010.10128.x
28
Zihan Ran, Wenjie Chen, Jun Shang, Xuemei Li, Zhiyan Nie, Jingcheng Yang, Na Li. Clinicopathological and prognostic implications of polo-like kinase 1 expression in colorectal cancer: A systematic review and meta-analysisGene 2019; 721: 144097 doi: 10.1016/j.gene.2019.144097
29
Jung-Sun Park, Hyun-Jung Sohn, Gyeong-Sin Park, Yeun-Jun Chung, Tai-Gyu Kim. Induction of antitumor immunity using dendritic cells electroporated with Polo-like kinase 1 (Plk1) mRNA in murine tumor modelsCancer Science 2011; 102(8): 1448 doi: 10.1111/j.1349-7006.2011.01974.x
30
Eman H. Yousef, Mohamed E El-Mesery, Maha R Habeeb, Laila A Eissa. Polo-like kinase 1 as a promising diagnostic biomarker and potential therapeutic target for hepatocellular carcinomaTumor Biology 2020; 42(4): 101042832091447 doi: 10.1177/1010428320914475
31
Nitin Sharma, Rajni Vaid, Kamal Dev, Anuradha Sourirajan. Encyclopedia of Signaling Molecules2018; : 4100 doi: 10.1007/978-3-319-67199-4_101760
32
Zewen Song, Zhaomei Yu, Limin Chen, Zhijiao Zhou, Qiong Zou, Yang Liu. MicroRNA-1181 supports the growth of hepatocellular carcinoma by repressing AXIN1Biomedicine & Pharmacotherapy 2019; 119: 109397 doi: 10.1016/j.biopha.2019.109397
33
Pauline Hascoet, Franck Chesnel, Cathy Le Goff, Xavier Le Goff, Yannick Arlot-Bonnemains. Unconventional Functions of Mitotic Kinases in Kidney TumorigenesisFrontiers in Oncology 2015; 5 doi: 10.3389/fonc.2015.00241
34
Otília Menyhárt, Ádám Nagy, Balázs Győrffy. Determining consistent prognostic biomarkers of overall survival and vascular invasion in hepatocellular carcinomaRoyal Society Open Science 2018; 5(12): 181006 doi: 10.1098/rsos.181006
35
Yingai Zhang, Shunlan Wang, Jingchuan Xiao, Hailong Zhou. Bioinformatics analysis to identify the key genes affecting the progression and prognosis of hepatocellular carcinomaBioscience Reports 2019; 39(2) doi: 10.1042/BSR20181845
36
Piotr Donizy, Agnieszka Halon, Pawel Surowiak, Maciej Kaczorowski, Cyprian Kozyra, Rafal Matkowski. Augmented expression of Polo-like kinase 1 is a strong predictor of shorter cancer-specific overall survival in early stage breast cancer at 15-year follow-upOncology Letters 2016; 12(3): 1667 doi: 10.3892/ol.2016.4890
37
James Ahodantin, Myriam Bou-Nader, Corinne Cordier, Jérôme Mégret, Patrick Soussan, Chantal Desdouets, Dina Kremsdorf. Hepatitis B virus X protein promotes DNA damage propagation through disruption of liver polyploidization and enhances hepatocellular carcinoma initiationOncogene 2019; 38(14): 2645 doi: 10.1038/s41388-018-0607-3
38
Neval Akdeli, Kathrin Riemann, Jana Westphal, Jochen Hess, Winfried Siffert, Hagen S Bachmann. A 3′UTR polymorphism modulates mRNA stability of the oncogene and drug target Polo-like Kinase 1Molecular Cancer 2014; 13(1): 87 doi: 10.1186/1476-4598-13-87